wire - news in brief

A new international observational study offers hope for children with Noonan syndrome, a rare genetic disorder that can thicken the wall of the heart. Could a cancer drug already on the market be used to treat certain children with a rare genetic disorder called Noonan syndrome (NS)- A new retrospective study by doctors and scientists at 27 institutions worldwide suggests that yes, it can.

One Health research in Faculty of Veterinary Medicine has important implications for parasite control programs in low-income countries A research team within the University of Calgary's Faculty of Vet

Two UdeM professors have co-authored and published the first Canadian guidelines for better detection, management and treatment of cystic fibrosis-related diabetes.

UCalgary research selected by CIHR to investigate a drug designed to protect brain cells after an ischemic stroke You've had an ischemic stroke, the most common form of stroke.

A recent study confirmed the effectiveness of six different methods for removing cytotoxic drugs from the arms of chairs in outpatient oncology clinics.

A research team is working to develop a method to reactivate latent HIV in virus carriers in order to eliminate it from the body permanently.

The use of antidepressants is associated with sexual side effects including reduced genital sensitivity that persists after stopping the medication, a new Simon Fraser University study finds.

A new professor in the Faculty of Pharmacy, Legault is using innovative techniques in genetics and AI to predict patients' responses to medication.

As academics and scientists around the world seek the best way to navigate the fast-growing world of artificial intelligence (AI), a Schulich School of Medicine & Dentistry student has incorporated th

It's a tug of war - a constantly evolving battle between antibiotics and the bacteria they are designed to kill. And experts say bacteria are winning. But a dedicated team of researchers at Schulich School of Medicine & Dentistry are laser-focused on what seems like an impossible task: Creating drugs to fight - and win - the war against antibiotic-resistant bacteria.

Sylvain Meloche's team has created a preclinical model to study hepatocellular carcinoma, the most common subtype of liver cancer, in order to develop new targeted therapies. The team led by Sylvain Meloche , Professor in the Faculty of Medicine at UdeM and Director of IRIC's Signalling and Cell Growth Research Unit, has developed a new preclinical model for the study of the most common subtype of liver cancer.

Researchers at Université de Montréal's teaching hospital say the discovery could help lessen and even eliminate viral loads in people undergoing antiretroviral therapy.

For the last decade, people who use drugs in Quebec have been partially sheltered from Canada's drug overdose epidemics. But since 2020, the picture has changed. The contamination of the drug market is now present in Quebec, and what happened in British Columbia and Ontario is now happening here, says expert Sarah Larney.

A deeper understanding of the communication inside the body when someone is going through opioid withdrawal has led to a new clinical trial at the University of Calgary.

Waterloo researchers awarded more than $4.3 million. University of Waterloo researchers take pride in identifying and solving significant, complex challenges facing humanity and our planet.

When long-term users of prescription opioids in Canada were mailed a brochure encouraging them to cut their dosages, many of them did - and that's a good thing, researchers say.

Coronary artery disease (CAD) is the most common type of heart disease, impacting  2.6 million Canadians.

Between 2010 and 2020, Quebec doctors became more likely to recommend physical activity for certain diseases but less likely to prescribe it for primary prevention or for obese patients.

A UdeM researcher is launching a study to test whether virtual reality can relieve anxiety and pain in palliative care.

Robert Miller creates software to help determine most appropriate test for coronary artery disease patients Coronary artery disease (CAD) is the most common type of heart disease, and a leading cause of death for both men and women in Canada.

New research led by a University of Calgary clinical research fellow is shedding light on the impact of a specialized clinic for pregnant women diagnosed with hypertension, a condition related to high blood pressure that can result in serious long-term health complications if untreated.

Measles usually begins with fever, runny nose, conjunctivitis (red watery eyes), sore throat and coughing Canada is seeing a resurgence of measles, with cases in the first quarter of 2024 already far surpassing the total for all'of 2023.

New School of Optometry & Vision Science research centre poised to make advancements in understanding diseases and conditions of the eye and beyond A new research centre at the University of Waterloo

Researchers share what motivates them to continue their work despite harsh scrutiny and misinformation  By Jenna Braun Faculty of Health The rapid spread of misinformation is rampant in the highly politicized area of health research.

New UBC research reveals a safe path to overcoming food allergies for older children and others who can't risk consuming allergens orally to build up their resistance.

Canada has been experiencing an increasing number of syphilis diagnoses since 2016 . Numerous provinces have declared outbreaks in recent years, with the highest rates observed in the Northwest Territories, Saskatchewan and Manitoba.

Waterloo Pharmacy PhD candidate receives graduate student scholarship from Parkinson Society Southwestern Ontario Milana Madzarac The Parkinson Society of Southwestern (PSSO) Ontario honoured Yusheng

A team of UBC researchers wants to help people living with cancer incorporate exercise as an important part of their treatment and recovery.

Atrial fibrillation (AF) is the most common heart rhythm disorder and is linked to severe impairments in quality of life and an increased risk of mortality due to stroke and heart failure.

Hypnosis can improve the quality of life of people suffering from chronic pain, according to a new research led by UdeM associate medical professor David Ogez.